244 related articles for article (PubMed ID: 21123455)
21. High glucose enhances interleukin-6-induced vascular endothelial growth factor 165 expression via activation of gp130-mediated p44/42 MAPK-CCAAT/enhancer binding protein signaling in gingival fibroblasts.
Omori K; Naruishi K; Nishimura F; Yamada-Naruishi H; Takashiba S
J Biol Chem; 2004 Feb; 279(8):6643-9. PubMed ID: 14676217
[TBL] [Abstract][Full Text] [Related]
22. A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitor.
Ancey C; Küster A; Haan S; Herrmann A; Heinrich PC; Müller-Newen G
J Biol Chem; 2003 May; 278(19):16968-72. PubMed ID: 12646580
[TBL] [Abstract][Full Text] [Related]
23. Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress.
Chen Q; Wang WC; Bruce R; Li H; Schleider DM; Mulbury MJ; Bain MD; Wallace PK; Baumann H; Evans SS
Immunity; 2004 Jan; 20(1):59-70. PubMed ID: 14738765
[TBL] [Abstract][Full Text] [Related]
24. Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.
Le TT; Karmouty-Quintana H; Melicoff E; Le TT; Weng T; Chen NY; Pedroza M; Zhou Y; Davies J; Philip K; Molina J; Luo F; George AT; Garcia-Morales LJ; Bunge RR; Bruckner BA; Loebe M; Seethamraju H; Agarwal SK; Blackburn MR
J Immunol; 2014 Oct; 193(7):3755-68. PubMed ID: 25172494
[TBL] [Abstract][Full Text] [Related]
25. Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic mice.
Brunello AG; Weissenberger J; Kappeler A; Vallan C; Peters M; Rose-John S; Weis J
Am J Pathol; 2000 Nov; 157(5):1485-93. PubMed ID: 11073809
[TBL] [Abstract][Full Text] [Related]
26. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
[TBL] [Abstract][Full Text] [Related]
27. Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma.
Mehner C; Miller E; Hockla A; Coban M; Weroha SJ; Radisky DC; Radisky ES
Oncogene; 2020 Oct; 39(42):6606-6618. PubMed ID: 32929152
[TBL] [Abstract][Full Text] [Related]
28. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF
Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
30. Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells.
Fan LL; Chen X; Zhang XY; Li ZM; Fan XM; Shen Y
Med Sci Monit; 2020 Aug; 26():e922612. PubMed ID: 32829374
[TBL] [Abstract][Full Text] [Related]
31. Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunity.
Lissilaa R; Buatois V; Magistrelli G; Williams AS; Jones GW; Herren S; Shang L; Malinge P; Guilhot F; Chatel L; Hatterer E; Jones SA; Kosco-Vilbois MH; Ferlin WG
J Immunol; 2010 Nov; 185(9):5512-21. PubMed ID: 20870936
[TBL] [Abstract][Full Text] [Related]
32. Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells.
Huang YH; Yang HY; Hsu YF; Chiu PT; Ou G; Hsu MJ
Angiogenesis; 2014 Apr; 17(2):407-18. PubMed ID: 24048742
[TBL] [Abstract][Full Text] [Related]
33. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
34. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.
Hasumi Y; Mizukami H; Urabe M; Kohno T; Takeuchi K; Kume A; Momoeda M; Yoshikawa H; Tsuruo T; Shibuya M; Taketani Y; Ozawa K
Cancer Res; 2002 Apr; 62(7):2019-23. PubMed ID: 11929819
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6
Chehboun S; Labrecque-Carbonneau J; Pasquin S; Meliani Y; Meddah B; Ferlin W; Sharma M; Tormo A; Masson JF; Gauchat JF
J Biol Chem; 2017 Apr; 292(16):6644-6656. PubMed ID: 28280243
[TBL] [Abstract][Full Text] [Related]
36. Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling.
Xiao J; Xu M; Hou T; Huang Y; Yang C; Li J
Mol Med Rep; 2015 Sep; 12(3):3249-3256. PubMed ID: 25975261
[TBL] [Abstract][Full Text] [Related]
37. Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formation.
Chou CC; Hua KT; Chen MW; Wu CJ; Hsu CH; Wang JT; Hsiao M; Wei LH
MAbs; 2022; 14(1):2029675. PubMed ID: 35133941
[TBL] [Abstract][Full Text] [Related]
38. Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.
Agarwal A; Tressel SL; Kaimal R; Balla M; Lam FH; Covic L; Kuliopulos A
Cancer Res; 2010 Jul; 70(14):5880-90. PubMed ID: 20570895
[TBL] [Abstract][Full Text] [Related]
39. Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429.
Guo Q; Lu L; Liao Y; Wang X; Zhang Y; Liu Y; Huang S; Sun H; Li Z; Zhao L
Cell Death Dis; 2018 Jan; 8(1):e3178. PubMed ID: 29324735
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer.
Dijkgraaf EM; Welters MJ; Nortier JW; van der Burg SH; Kroep JR
Curr Pharm Des; 2012; 18(25):3816-27. PubMed ID: 22591418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
